Prescription revenues and market share from specialty pharmaceuticals, by company, 2018
| Pharmacy | Parent organization | Estimated prescription revenue from specialty drugs (2018, US$ billions) | Change in revenue 2018 vs 2017 (%) | Share of prescription revenues from specialty drugs (%) |
|---|---|---|---|---|
| CVS specialty/Aetna specialty | CVS health | $37.0 | +6 | 25 |
| Accredit/freedom fertility/Cigna specialty | Cigna/express scripts | $30.7 | +7 | 21 |
| Alliance Rx Walgreens prime/Walgreens stores | Walgreens boots alliance | $19.6 | +23 | 13 |
| BriovaRx | UnitedHealth group | $16.8 | +29 | 11 |
| Diplomat pharmacy | Diplomat pharmacy | $4.8 | +6 | 3 |
| Humana specialty | Humana | $3.2 | +3 | 2 |
| Kroger specialty/Kroger stores | Kroger | $2.8 | +24 | 2 |
| Specialty pharmacy solutions | Mckesson | $1.6 | +7 | 1 |
| US Bioservices | AmerisourceBergen | $1.4 | +23 | 1 |
| Walmart specialty | Walmart | $1.0 | +4 | 1 |
| All other | n/a | $27.4 | n/a | 20 |
| Total | $146.2 | +6 | 100 |
| Pharmacy | Parent organization | Estimated prescription revenue from specialty drugs (2018, US$ billions) | Change in revenue 2018 vs 2017 (%) | Share of prescription revenues from specialty drugs (%) |
|---|---|---|---|---|
| CVS specialty/Aetna specialty | CVS health | $37.0 | +6 | 25 |
| Accredit/freedom fertility/Cigna specialty | Cigna/express scripts | $30.7 | +7 | 21 |
| Alliance Rx Walgreens prime/Walgreens stores | Walgreens boots alliance | $19.6 | +23 | 13 |
| BriovaRx | UnitedHealth group | $16.8 | +29 | 11 |
| Diplomat pharmacy | Diplomat pharmacy | $4.8 | +6 | 3 |
| Humana specialty | Humana | $3.2 | +3 | 2 |
| Kroger specialty/Kroger stores | Kroger | $2.8 | +24 | 2 |
| Specialty pharmacy solutions | Mckesson | $1.6 | +7 | 1 |
| US Bioservices | AmerisourceBergen | $1.4 | +23 | 1 |
| Walmart specialty | Walmart | $1.0 | +4 | 1 |
| All other | n/a | $27.4 | n/a | 20 |
| Total | $146.2 | +6 | 100 |
Notes:
Reprinted [adapted] from “The 2019 Economic Report on US Pharmacies and Pharmacy Benefit Managers,” by A. J. Fein (2019), Drug Channels Institute. Copyright 2019 by Pembroke Consulting, Inc., d/b/a Drug Channels Institute